{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dementia/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"ef7780bd-8e94-5f95-870f-92ab930c4365","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field 128cde9e-b093-4c79-888e-23427f0eea2a --><h2>What else could it be?</h2><!-- end field 128cde9e-b093-4c79-888e-23427f0eea2a -->","summary":"","htmlStringContent":"<!-- begin item 16952102-21f0-4b65-99b1-d5c70fa95f2e --><!-- begin field e7e58aa4-5fee-433b-847f-fd35cea4e192 --><ul><li><strong>Conditions that can present with similar symptoms to dementia include:</strong><ul><li><strong>Normal-age related memory changes</strong><ul><li>Normal ageing is associated with a mild decline in cognitive function, and memory lapses are common, especially during times of physical illness or stress.</li></ul></li><li><strong>Mild cognitive impairment (MCI)</strong><ul><li>MCI differs from dementia in that symptoms do not fulfil the <a class=\"topic-reference internal-reference\" href=\"/topics/dementia/background-information/\">diagnostic criteria</a> for dementia, for example only one cognitive domain may be affected or activities of daily life may not be significantly affected.</li><li>Of people with MCI, 50% will later develop dementia.</li></ul></li><li><strong>Depression</strong><ul><li>Symptoms of depression include low mood, loss of interest, anhedonia, and self-neglect which can be similar to those of dementia.</li><li>In older people, features of depression may be less obvious, with somatic symptoms (such as reduced appetite, fatigue, and insomnia) are more common.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>.</li></ul></li><li><strong>Delirium</strong><ul><li>Delirium (sometimes called 'acute confusional state') is an acute, fluctuating syndrome of disturbed consciousness, attention, cognition, and perception. It is a common condition in the differential diagnosis for dementia.</li><li>People with cognitive impairment are at increased risk of delirium, and the two conditions often coexist.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/delirium/\">Delirium</a>.</li></ul></li><li><strong>Vitamin deficiency</strong><ul><li>Thiamine deficiency can lead to Wernicke encephalopathy and Korsakoff psychosis. Symptoms include confusion, memory loss, problems with learning new information and gait disturbances.</li><li>Vitamin B12 deficiency can lead to ataxia, psychiatric abnormalities, memory loss, and gait disturbance.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a>.</li></ul></li><li><strong>Hypothyroidism</strong><ul><li>Symptoms of hypothyroidism can include low mood, and impaired concentration and memory.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a>. </li></ul></li><li><strong>Adverse drug effects</strong><ul><li>Many drugs, including benzodiazepines, analgesics (such as opioids, naproxen, and ibuprofen), anticholinergics, anti-depressants (such as tricyclics), antipsychotics (such as haloperidol), anti-convulsants (especially older preparations, such as phenytoin and phenobarbital), and corticosteroids can affect cognition.</li><li>Concomitant use of medication increases the risk of drug interactions and drug-induced confusion.</li><li>In older people, drugs may be metabolized and excreted more slowly therefore, toxicity can occur with normal doses and present as dementia or delirium.</li></ul></li><li><strong>Normal pressure hydrocephalus</strong><ul><li>Normal pressure hydrocephalus can present with symptoms of early cognitive impairment, urinary incontinence, and gait disorder.</li></ul></li><li><strong>Sensory deficits</strong><ul><li>Problems with vision and hearing can contribute significantly to an apparent decline in cognitive ability.</li></ul></li></ul></li></ul><!-- end field e7e58aa4-5fee-433b-847f-fd35cea4e192 --><!-- end item 16952102-21f0-4b65-99b1-d5c70fa95f2e -->","topic":{"id":"de9cbb4d-2d69-500f-be27-dc83f76dc3ba","topicId":"2491e3e7-cc21-42b9-8972-e54804b4782f","topicName":"Dementia","slug":"dementia","lastRevised":"Last revised in October 2020","chapters":[{"id":"af834011-0042-530a-8f9a-acd5828e0a34","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a0360b83-4555-5079-897f-12b2d555c1af","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"52cd8e36-39cd-5259-8819-bd96087b0265","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"60bd6b27-027f-56a6-a018-a1d694a6a2f3","slug":"changes","fullItemName":"Changes"},{"id":"7ced1224-30c2-5f30-9caf-3764f3665ae4","slug":"update","fullItemName":"Update"}]},{"id":"fae05cff-ad98-52fa-89b4-b97369195d59","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2f3b4bd3-e7cf-5492-afe0-0a5b230eab7e","slug":"goals","fullItemName":"Goals"},{"id":"9104785e-e491-5ca3-b3d3-7e951385bce9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a9c56eb4-bc0e-51cc-b486-a54c23906bc0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebf62eba-a4cd-536c-8c9f-c9505b0e7482","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a71b8dc2-79f8-5d24-b668-c792abc5a624","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c87232ba-6926-5ff2-98d2-f8839b0c0d37","slug":"nice-quality-standards","fullItemName":"NICE Quality Standards"}]},{"id":"825c29c3-9d55-54ae-b54d-8ee2ac796e97","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"46c6316f-eec0-580a-80ec-2112d2f0122f","slug":"definition","fullItemName":"Definition"},{"id":"f485482d-0d4e-52cb-9df4-3548bc72a566","slug":"causes","fullItemName":"Causes"},{"id":"87101d89-6073-57cc-b247-48be586ef185","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"58f6ec5a-c90b-5e64-a476-fc9fca39c6ae","slug":"prevalence","fullItemName":"Prevalence"},{"id":"994469e3-f824-5f48-b755-7f74dd360680","slug":"prognosis","fullItemName":"Prognosis"},{"id":"718f9ed4-d725-5f6e-a86f-5df88719cd52","slug":"complications","fullItemName":"Complications"}]},{"id":"366bcbe3-827a-5e08-9d81-8de84e46fefd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"565bac2a-ada3-5b0a-ab7d-6681501b2c4a","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"4c0fe55f-40c9-5a1c-8cf3-1ec8d88406d5","slug":"assessment","fullItemName":"Assessment"},{"id":"ef7780bd-8e94-5f95-870f-92ab930c4365","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3069f5e5-519f-50ec-81b7-c8948a5b3117","fullItemName":"Management","slug":"management","subChapters":[{"id":"c6c0cbc2-18fc-5bf8-973d-bc38b9001f28","slug":"suspected-dementia","fullItemName":"Scenario: Suspected dementia"},{"id":"6320a2da-e9d6-5f57-94d9-0433261edf89","slug":"follow-up-of-confirmed-dementia-in-primary-care","fullItemName":"Scenario: Follow up of confirmed dementia in primary care"},{"id":"343a59fa-439e-5ab9-9d3b-28a893d55d2f","slug":"management-of-end-stage-dementia","fullItemName":"Scenario: Management of end-stage dementia"}]},{"id":"9a2639de-07aa-5fe3-8f09-5c005f9c29dd","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"58ed8441-e3ca-566e-9afb-92a5ba60b1dd","slug":"haloperidol","fullItemName":"Haloperidol"},{"id":"67092bd7-2ab4-5e8b-8ead-5301454da4a8","slug":"acetylcholinesterase-inhibitors","fullItemName":"Acetylcholinesterase inhibitors"},{"id":"f4ced652-a6de-5e19-ae37-6de43dfd8104","slug":"lorazepam","fullItemName":"Lorazepam"},{"id":"45d5f01b-c1c2-53dc-91b4-8f7a90983fd5","slug":"memantine-hydrochloride","fullItemName":"Memantine hydrochloride"}]},{"id":"1e87c908-2ab5-5cba-8d6a-958c03f7a6cd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fc7a2bcf-854b-5ca4-9b02-2dcaaebe1162","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7bcb26a3-cc69-5201-9fd9-6353e27b412f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0c383917-58d0-5036-8217-5d9fd81cb2cb","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"fdb8af52-aeee-52bd-be79-c5534939d42f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a9f930f3-f8b6-5c8f-b8ca-b3155e0c23d3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"668c11fa-1873-58d4-b0e2-3eab90e8fbff","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"67c4aef9-fbf4-5bf6-8dc5-c501f74b1fe3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"366bcbe3-827a-5e08-9d81-8de84e46fefd","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"32152012-876c-5a6b-8b85-b4f75e99eb58","slug":"basis-for-recommendation-e50","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 0612e85d-8ec0-499c-bf26-f79eecbb2ae0 --><h3>Basis for recommendation</h3><!-- end field 0612e85d-8ec0-499c-bf26-f79eecbb2ae0 -->","summary":null,"htmlStringContent":"<!-- begin item e5028a2e-2b5d-4afb-aebd-68df9a30f5d7 --><!-- begin field fd50c689-4d7a-4419-b246-3322a87ef35c --><p>The information on differential diagnosis is based on the National Institute for Health and Care Excellence (NICE) guideline <em>Dementia: supporting people with dementia and their carers in health and social care (CG42)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE, 2006</a>], the Guidelines and Protocols Advisory Committee (GPAC) guideline <em>Cognitive impairment: recognition, diagnosis and management in primary care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">GPAC, 2014</a>], the US preventative task-force statement <em>Cognitive impairment in older adults: screening</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Moyer, 2014</a>], and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Moore and O'Keefe, 1999</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Iliffe, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Young, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Galvin, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Barrett, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">BMJ Best Practice, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">Robinson, 2015</a>].</p><!-- end field fd50c689-4d7a-4419-b246-3322a87ef35c --><!-- end item e5028a2e-2b5d-4afb-aebd-68df9a30f5d7 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}